Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Suppression of breakthrough bleeding in levonorgestrel intrauterine system (Mirena system) users

Trial Profile

Suppression of breakthrough bleeding in levonorgestrel intrauterine system (Mirena system) users

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2010

At a glance

  • Drugs Ulipristal (Primary)
  • Indications Metrorrhagia
  • Focus Therapeutic Use
  • Acronyms MUSE
  • Most Recent Events

    • 01 Feb 2010 Results published in Human Reproduction.
    • 23 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top